374 related articles for article (PubMed ID: 23674757)
1. STAT3 activates miR-155 in Th17 cells and acts in concert to promote experimental autoimmune uveitis.
Escobar T; Yu CR; Muljo SA; Egwuagu CE
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4017-25. PubMed ID: 23674757
[TBL] [Abstract][Full Text] [Related]
2. STAT3-Specific Single Domain Nanobody Inhibits Expansion of Pathogenic Th17 Responses and Suppresses Uveitis in Mice.
Mbanefo EC; Yan M; Kang M; Alhakeem SA; Jittayasothorn Y; Yu CR; Parihar A; Singh S; Egwuagu CE
Front Immunol; 2021; 12():724609. PubMed ID: 34603297
[TBL] [Abstract][Full Text] [Related]
3. Novel IL27p28/IL12p40 cytokine suppressed experimental autoimmune uveitis by inhibiting autoreactive Th1/Th17 cells and promoting expansion of regulatory T cells.
Wang RX; Yu CR; Mahdi RM; Egwuagu CE
J Biol Chem; 2012 Oct; 287(43):36012-21. PubMed ID: 22936807
[TBL] [Abstract][Full Text] [Related]
4. Loss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseases.
Liu X; Lee YS; Yu CR; Egwuagu CE
J Immunol; 2008 May; 180(9):6070-6. PubMed ID: 18424728
[TBL] [Abstract][Full Text] [Related]
5. STAT3 deficiency in B cells exacerbates uveitis by promoting expansion of pathogenic lymphocytes and suppressing regulatory B cells (Bregs) and Tregs.
Oladipupo FO; Yu CR; Olumuyide E; Jittaysothorn Y; Choi JK; Egwuagu CE
Sci Rep; 2020 Oct; 10(1):16188. PubMed ID: 33004854
[TBL] [Abstract][Full Text] [Related]
6. miR-182-5p inhibits the pathogenic Th17 response in experimental autoimmune uveitis mice via suppressing TAF15.
Zhang L; Sun P; Zhang Y; Xu Y; Sun Y
Biochem Biophys Res Commun; 2020 Aug; 529(3):784-792. PubMed ID: 32736708
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic targeting of STAT3 (signal transducers and activators of transcription 3) pathway inhibits experimental autoimmune uveitis.
Yu CR; Lee YS; Mahdi RM; Surendran N; Egwuagu CE
PLoS One; 2012; 7(1):e29742. PubMed ID: 22238646
[TBL] [Abstract][Full Text] [Related]
8. SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune uveitis (EAU).
Vistica BP; Shi G; Nugent L; Tan C; Altman A; Gery I
Mol Vis; 2012; 18():1858-64. PubMed ID: 22815639
[TBL] [Abstract][Full Text] [Related]
9. Autoreactive memory CD4+ T lymphocytes that mediate chronic uveitis reside in the bone marrow through STAT3-dependent mechanisms.
Oh HM; Yu CR; Lee Y; Chan CC; Maminishkis A; Egwuagu CE
J Immunol; 2011 Sep; 187(6):3338-46. PubMed ID: 21832158
[TBL] [Abstract][Full Text] [Related]
10. Breakdown of immune privilege and spontaneous autoimmunity in mice expressing a transgenic T cell receptor specific for a retinal autoantigen.
Horai R; Silver PB; Chen J; Agarwal RK; Chong WP; Jittayasothorn Y; Mattapallil MJ; Nguyen S; Natarajan K; Villasmil R; Wang P; Karabekian Z; Lytton SD; Chan CC; Caspi RR
J Autoimmun; 2013 Aug; 44():21-33. PubMed ID: 23810578
[TBL] [Abstract][Full Text] [Related]
11. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
[TBL] [Abstract][Full Text] [Related]
12. Comparative Analysis of the Interphotoreceptor Retinoid Binding ProteinInduced Models of Experimental Autoimmune Uveitis in B10.RIII versus C57BL/6 Mice.
Chen Y; Chen Z; Chong WP; Wu S; Wang W; Zhou H; Chen J
Curr Mol Med; 2018; 18(9):602-611. PubMed ID: 30636608
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of IL-27 Signaling Exacerbates Experimental Autoimmune Uveitis with Elevated Uveitogenic Th1 and Th17 Responses.
Wu S; Ma R; Zhong Y; Chen Z; Zhou H; Zhou M; Chong W; Chen J
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299138
[TBL] [Abstract][Full Text] [Related]
14. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation.
Oh K; Byoun OJ; Ham DI; Kim YS; Lee DS
Eur J Immunol; 2011 Feb; 41(2):392-402. PubMed ID: 21268009
[TBL] [Abstract][Full Text] [Related]
15. Parental Uveitis Influences Offspring With an Increased Susceptibility to the Experimental Autoimmune Uveitis.
Yin G; Zeng W; Hu K; Gao J; Liu J; Chen Y; Chen F
Front Immunol; 2020; 11():1053. PubMed ID: 32612602
[No Abstract] [Full Text] [Related]
16. AS101 ameliorates experimental autoimmune uveitis by regulating Th1 and Th17 responses and inducing Treg cells.
Bing SJ; Shemesh I; Chong WP; Horai R; Jittayasothorn Y; Silver PB; Sredni B; Caspi RR
J Autoimmun; 2019 Jun; 100():52-61. PubMed ID: 30853312
[TBL] [Abstract][Full Text] [Related]
17. [Effects of exogenous interleukin-2, interleukin-23 on differentiation of IRBP 1-20-specific T cells toward Th1 and Th17 and comparison of the pathogenicity of IRBP 1-20-specific T cells].
Li Y; Cui Y; Bi HS; Wang Y; Li J; Wang XR
Zhonghua Yan Ke Za Zhi; 2013 Mar; 49(3):224-9. PubMed ID: 23866703
[TBL] [Abstract][Full Text] [Related]
18. EBI3 is pivotal for the initiation of experimental autoimmune uveitis.
Takeda A; Hasegawa E; Fukuhara T; Hirakawa S; Yamada H; Yang Y; Yoshimura T; Hisatomi T; Oshima Y; Yoshida H; Sonoda KH; Ishibashi T
Exp Eye Res; 2014 Aug; 125():107-13. PubMed ID: 24929202
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic Function of Herpesvirus Entry Mediator in Experimental Autoimmune Uveitis by Induction of Th1- and Th17-Type T Cell Responses.
Sakoda Y; Nagai T; Murata S; Mizuno Y; Kurosawa H; Shoda H; Morishige N; Yanai R; Sonoda KH; Tamada K
J Immunol; 2016 Apr; 196(7):2947-54. PubMed ID: 26912321
[TBL] [Abstract][Full Text] [Related]
20. Regulatory effects of IFN-β on the development of experimental autoimmune uveoretinitis in B10RIII mice.
Sun M; Yang Y; Yang P; Lei B; Du L; Kijlstra A
PLoS One; 2011 May; 6(5):e19870. PubMed ID: 21573074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
